Literature DB >> 12839997

Evidence that reactive oxygen species do not mediate NF-kappaB activation.

Makio Hayakawa1, Hiroshi Miyashita, Isao Sakamoto, Masatoshi Kitagawa, Hirofumi Tanaka, Hideyo Yasuda, Michael Karin, Kiyomi Kikugawa.   

Abstract

It has been postulated that reactive oxygen species (ROS) may act as second messengers leading to nuclear factor (NF)-kappaB activation. This hypothesis is mainly based on the findings that N-acetyl-L-cysteine (NAC) and pyrrolidine dithiocarbamate (PDTC), compounds recognized as potential antioxidants, can inhibit NF-kappaB activation in a wide variety of cell types. Here we reveal that both NAC and PDTC inhibit NF-kappaB activation independently of antioxidative function. NAC selectively blocks tumor necrosis factor (TNF)-induced signaling by lowering the affinity of receptor to TNF. PDTC inhibits the IkappaB-ubiquitin ligase activity in the cell-free system where extracellular stimuli-regulated ROS production does not occur. Furthermore, we present evidence that endogenous ROS produced through Rac/NADPH oxidase do not mediate NF-kappaB signaling, but instead lower the magnitude of its activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12839997      PMCID: PMC165656          DOI: 10.1093/emboj/cdg332

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways.

Authors:  T Maniatis
Journal:  Genes Dev       Date:  1999-03-01       Impact factor: 11.361

4.  Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway.

Authors:  M T Anderson; F J Staal; C Gitler; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 5.  Redox regulation of NF-kappa B activation.

Authors:  L Flohé; R Brigelius-Flohé; C Saliou; M G Traber; L Packer
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

Review 6.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

7.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

Review 8.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  Pyrrolidine dithiocarbamate inhibits TNF-alpha-dependent activation of NF-kappaB by increasing intracellular copper level in human aortic smooth muscle cells.

Authors:  A Iseki; F Kambe; K Okumura; S Niwata; R Yamamoto; T Hayakawa; H Seo
Journal:  Biochem Biophys Res Commun       Date:  2000-09-16       Impact factor: 3.575

10.  Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.

Authors:  G Bonizzi; J Piette; S Schoonbroodt; R Greimers; L Havard; M P Merville; V Bours
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

View more
  104 in total

1.  Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant function.

Authors:  Zhekang Ying; Thomas Kampfrath; Qinghua Sun; Sampath Parthasarathy; Sanjay Rajagopalan
Journal:  Inflamm Res       Date:  2010-10-07       Impact factor: 4.575

2.  CREB and NF-kappaB transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death.

Authors:  Jian Zou; Fulton Crews
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

Review 3.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

4.  The IkappaB kinase regulates chromatin structure during reconsolidation of conditioned fear memories.

Authors:  Farah D Lubin; J David Sweatt
Journal:  Neuron       Date:  2007-09-20       Impact factor: 17.173

5.  NF-kappaB signaling differentially regulates influenza virus RNA synthesis.

Authors:  Naveen Kumar; Zhong-Tao Xin; Yuhong Liang; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

6.  Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway.

Authors:  K M Graham; R Singh; G Millman; G Malnassy; F Gatti; K Bruemmer; C Stefanski; H Curtis; J Sesti; C G Carlson
Journal:  J Neurol Sci       Date:  2010-05-13       Impact factor: 3.181

7.  Effects of 10 weeks of regular running exercise with and without parallel PDTC treatment on expression of genes encoding sarcomere-associated proteins in murine skeletal muscle.

Authors:  Angelika Schmitt; Anne-Lena Haug; Franziska Schlegel; Annunziata Fragasso; Barbara Munz
Journal:  Cell Stress Chaperones       Date:  2018-05-24       Impact factor: 3.667

8.  Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-κB and oxidative stress.

Authors:  Felipe A Pinho-Ribeiro; Victor Fattori; Ana C Zarpelon; Sergio M Borghi; Larissa Staurengo-Ferrari; Thacyana T Carvalho; Jose C Alves-Filho; Fernando Q Cunha; Thiago M Cunha; Rubia Casagrande; Waldiceu A Verri
Journal:  Inflammopharmacology       Date:  2016-05-09       Impact factor: 4.473

9.  Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines.

Authors:  Sandra Levrand; Benoît Pesse; François Feihl; Bernard Waeber; Pal Pacher; Joëlle Rolli; Marie-Denise Schaller; Lucas Liaudet
Journal:  J Biol Chem       Date:  2005-08-03       Impact factor: 5.157

10.  A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons.

Authors:  Laura Orio; Noemi Llopis; Elisa Torres; Maria Izco; Esther O'Shea; M Isabel Colado
Journal:  Neurotox Res       Date:  2009-09-24       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.